Minimal cognitive impairment in UK HIV-positive men who have sex with men: Effect of case definitions and comparison with the general population and HIV-negative men

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 2, 2014, Pages 120-127

  McDonnell, Jeffrey ^a   Haddow, Lewis ^a   Daskalopoulou, Marina ^a   Lampe, Fiona ^a   Speakman, Andrew ^a   Gilson, Richard ^a   Phillips, Andrew ^a   Sherr, Lorraine ^a   Wayal, Sonali ^a   Harrison, John ^b   Antinori, Andrea ^c   Maruff, Paul ^d   Schembri, Adrian ^d   Johnson, Margaret ^e   Collins, Simon ^f   Rodger, Alison ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d CogState ^*  (Australia)

^e ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^f c o HIV i Base   (United Kingdom)

Author keywords

Cognition disorders; Cross sectional studies; HIV infections; Men who have sex with men; Neuropsychological tests

Indexed keywords

ADULT; AGE; AGED; ALGORITHM; ANXIETY; ARTICLE; CATEGORY FLUENCY TEST; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED ORAL WORD ASSSOCIATION TEST; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CRYPTOCOCCOSIS; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSESSMENT; EDUCATIONAL STATUS; FRASCATI CRITERIA; FUNCTIONAL DISEASE; GLOBAL DEFICIT SCORE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SENSITIVITY ANALYSIS; TOXOPLASMOSIS; UNITED KINGDOM; ADOLESCENT; COGNITION DISORDERS; COMPLICATION; ENGLAND; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUALITY; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LONDON; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84925297182     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000273     Document Type: Article

References (46)

1. d'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol. 2004; 55: 320-328.
2. Garvey LJ, Winston A, Walsh J, et al. HIV-Associated central nervous system diseases in the recent combination antiretroviral therapy era. Eur J Neurol. 2011; 18: 527-534.
3. Bhaskaran K, Mussini C, Antinori A, et al; CASCADE Collaboration. Changes in the incidence and predictors of human immunodeficiency virus associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008; 63: 213-221.
4. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010; 24: 1243-1250.
5. Heaton RK, Clifford DB, Franklin DRJ, et al. HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010; 75: 2087-2096.
6. Bonnet F, Amieva H, Marquant F, et al. Cognitive disorders in HIVinfected patients: Are they HIV-related? AIDS. 2013; 27: 391-400.
7. Tozzi V, Balestra P, Serraino D, et al. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses. 2005; 21: 706-713.
8. Bragança M, Palha A. Depression and neurocognitive performance in Portuguese patients infected with HIV. AIDS Behav. 2011; 15: 1879-1887.
9. Garvey LJ, Surendrakumar V, Winston A. Low rates of neurocognitive impairment are observed in neuro-Asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials. 2011; 12: 333-338.
10. Crum-Cianflone NF, Moore DJ, Letendre S, et al. Low prevalence of neurocognitive impairment in early diagnosed and managed HIVinfected persons. Neurology. 2013; 80: 371-379.
11. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIVassociated neurocognitive disorders. Neurology. 2007; 69: 1789-1799.
12. Gisslen M, Price RW, Nilsson S. The definition of HIV-Associated neurocognitive disorders: Are we overestimating the real prevalence? BMC Infect Dis. 2011; 11: 356.
13. Sadek JR, Vigil O, Grant I, et al. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol. 2007; 29: 266-276.
14. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2012. Stockholm: European Centre for Disease Prevention and Control; 2013.
15. Blackstone K, Moore DJ, Franklin DRJ, et al. Defining neurocognitive impairment in HIV: Deficit scores versus clinical ratings. Clin Neuropsychol. 2012; 26: 894-908.
16. Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of Global Deficit Scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004; 26: 307-319.
17. Speakman A, Rodger AJ, Phillips AN, et al. The "Antiretrovirals, sexual transmission risk and attitudes" (ASTRA) study. Design, methods and participant characteristics. PLoS One. 2013; 8: E77230.
18. Maruff P, Thomas E, Cysique LA, et al. Validity of the CogState brief battery: Relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009; 24: 165-178.
19. Cysique LAJ, Maruff P, Darby D, et al. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006; 21: 185-194.
20. Makdissi M, Collie A, Maruff P, et al. Computerised assessment of concussed Australian Rules footballers. Br J Sports Med. 2001; 35: 354-360.
21. Weaver Cargin J, Maruff P, Collie A, et al. Mild memory impairment in healthy older adults is distinct from normal aging. Brain Cogn. 2006; 60: 146-155.
22. Harrison J, Maruff P. Measuring the mind: Assessing cognitive change in clinical drug trials. Expert Rev Clin Pharmacol. 2008; 1: 471-473.
23. Lim YY, Ellis KA, Harrington K, et al. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol. 2012; 34: 345-358.
24. Garvey LJ, Yerrakalva D, Winston A. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retroviruses. 2009; 25: 765-769.
25. Overton ET, Kauwe JS, Paul R, et al. Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav. 2011; 15: 1902-1909.
26. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179-186.
27. Gandhi NS, Skolasky RL, Peters KB, et al. A comparison of performance-based measures of function in HIV-Associated neurocognitive disorders. J Neurovirol. 2011; 17: 159-165.
28. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIVassociated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004; 10: 317-331.
29. Mayfield D, McLoed G, Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry. 1974; 131: 1121-1123.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
31. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006; 166: 1092-1097.
32. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999; 14: 167-177.
33. Ruff RM, Light RH, Parker SB, et al. Benton Controlled Oral Word Association Test: Reliability and updated norms. Arch Clin Neuropsychol. 1996; 11: 329-338.
34. Ingraham LJ, Aiken CB. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology. 1996; 10: 120-124.
35. Meyer AC, Boscardin WJ, Kwasa JK, et al. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIVAssociated Neurocognitive Disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 2013; 41: 208-216.
36. Iudicello JE, Woods SP, Deutsch R, et al. Combined effects of aging and HIV infection on semantic verbal fluency: A view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol. 2012; 34: 476-488.
37. Becker BW, Thames AD, Woo E, et al. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav. 2011; 15: 1888-1894.
38. Rothlind JC, Greenfield TM, Bruce AV, et al. Heavy alcohol consumption in individuals with HIV infection: Effects on neuropsychological performance. J Int Neuropsychol Soc. 2005; 11: 70-83.
39. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIVinfected adults: Effect of patient age, cognitive status, and substance abuse. AIDS 2004; 18: S19-S25.
40. Winston A, Arenas-Pinto A, Stoehr W, et al. Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One. 2013; 8: E61949.
41. Fisher M, Cooper V. HIV and ageing: Premature ageing or premature conclusions? Curr Opin Infect Dis. 2012; 25: 1-3.
42. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002; 8: 448-460.
43. Ritchie K, Carrière I, Ritchie CW, et al. Designing prevention programmes to reduce incidence of dementia: Prospective cohort study of modifiable risk factors. BMJ. 2010; 341: C3885.
44. Foley JM, Ettenhofer ML, Kim MS, et al. Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Appl Neuropsychol Adult. 2012; 19: 16-25.
45. Brew BJ, Letendre SL. Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry. 2008; 20: 73-88.
46. Tucker KA, Robertson KR, Lin W, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol. 2004; 157: 153-162.